Lung cancer is by far the most lethal form of cancer in the U.S., accounting for about 1 in 5 of all cancer deaths.
Johns Hopkins Medicine scientists say they have found a pattern of so-called epigenetic "marks" in a transition state between ...
13h
AccuStem Sciences, Inc. (OTCQB: ACUT), a clinical stage diagnostics company dedicated to improving outcomes for patients with or at risk of cancer, announces plans to launch its microRNA Signature ...
Scientists are looking for answers about how these confounding trips, known as metastases, occur throughout the human body ...
A new study validates NRG1 gene fusions as a targetable driver of advanced NRG1 fusion-positive cancers, adding support for ...
Lung cancer screening with low-dose CT could have saved tens of thousands of lives — if only we'd listened to the data back ...
An independent data monitoring board found that BeiGene’s ociperlimab was unlikely to significantly boost overall survival in ...
Camrelizumab combo doubled the five-year survival rate in advanced squamous lung cancer, reducing mortality risk by 43%, in a ...
On March 5, 2025, the FDA cleared an investigational new drug application for CTD402, a CD7-targeted universal CAR T-cell ...
New research delves into the DNA details and chromatin structures that may predict prognosis in early-stage lung ...
In a new study that challenges long-held views on lung cancer, University of Kentucky Markey Cancer Center researchers have ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback